A two-row flow chart between blood and a tumour cell: above, glucose enters by GLUT, becomes glucose-6-phosphate via hexokinase and goes on to glycolysis; below, FDG enters the same way and becomes FDG-6-phosphate, which cannot proceed in glycolysis and, with low glucose-6-phosphatase in tumour, is not reversed. A highlight moving along the arrows and boxes lighting up in turn show the order of conversion; trapped FDG-6-P is counted.

Glucose and FDG enter the cell through the same GLUT-1/3 transporters and are phosphorylated by hexokinase; the orange highlight follows this order along the arrows and the box it reaches lights up. Glucose-6-phosphate continues into glycolysis. FDG-6-phosphate cannot proceed in glycolysis (it is not a substrate of glucose-6-phosphate isomerase); glucose-6-phosphatase could reverse it, but its activity is low in tumour cells: both routes are closed (×) and FDG-6-P accumulates in the cell. In tumour, GLUT-1 expression and hexokinase activity are increased, so accumulation is greater; in tissue with high glucose-6-phosphatase (liver, some HCCs) FDG washes out.

Blood / interstitiumTumour cellGLUT-1/3GLUT-1/3hexokinaseGlucoseGlucoseGlucose-6-PGlycolysiscontinueshexokinase ↑glucose-6-phosphataselow in tumourF-18 FDGFDGFDG-6-PCannot enterglycolysistrapped FDG-6-P: 2METABOLIC TRAPPING → accumulates in the cellSchematic; the orange highlightshows the order of conversion.
Continuous stream · no seeking

FDG enters and is phosphorylated like glucose, but FDG-6-P cannot proceed in glycolysis and, with low glucose-6-phosphatase in tumour, is not reversed, so uptake reflects the cell's glucose use.

Source: mechanism from the book (21.1); an animated version of Figure 21.1; Gallagher et al. J Nucl Med 1978; Torizuka et al. J Nucl Med 1995. Molecule numbers and speeds representative.

How to use: a single click on the drawing pauses and resumes; use the time bar below to go to any point of the flow.

Did this animation help you understand the topic?

Metabolic trapping of FDG in the cell · Open in Nuclear Medicine Explained ↗